We are in the midst of a type 2 diabetes epidemic, and the consequences are profound. Type 2 diabetes leaves our population vulnerable to serious comorbidities, such as cardiovascular disease. Expanding evidence suggests a link between hypogonadism and type 2 diabetes mellitus and insulin resistance. The feature article by Abdulmaged M. Traish, MBA, PhD, examines the pathophysiology that may link these conditions and discusses how treating hypogonadism may improve the other two conditions and lead to better overall health. In the interview, Andre T. Guay, MD, describes how patients with hypogonadism and type 2 diabetes present in the clinical setting and offers practical tips for their treatment. Earn free CME credit by reading this issue of TU Times.

PDF

Flipbook